The changes of biological markers and treatment efficacy in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 2, 2001, Pages 323-335

  Cešková, Eva ^a   Drybčák, Pavel ^b   Hrobař, Petr ^a   Lorenc, Miroslav ^b   Procházková, Hana ^a   Špaček, Josef ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b Military Technical Institute of Protection   (Czech Republic)

Author keywords

Biological markers; Neuropsychology; Outcome; Schizophrenia

Indexed keywords

AMISULPRIDE; BIOLOGICAL MARKER; DEXAMETHASONE; HALOPERIDOL; HYDROCORTISONE; NEUROLEPTIC AGENT; PERPHENAZINE; SULPIRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; HEARING; HUMAN; HYDROCORTISONE BLOOD LEVEL; MEMORY; NEGATIVE SYNDROME; NEUROLOGIC EXAMINATION; PSYCHOLOGIC ASSESSMENT; PSYCHOMOTOR ACTIVITY; RATING SCALE; REACTION TIME; SCHIZOPHRENIA; SENSATION; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISION;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; BRAIN; COGNITION; DEXAMETHASONE; FOLLOW-UP STUDIES; HALOPERIDOL; HUMANS; HYDROCORTISONE; INPATIENTS; MEMORY; PERPHENAZINE; PSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULPIRIDE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035076468     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00164-0     Document Type: Article

References (24)

1. Memory impairment in schizophrenia: A meta-analysis
2. Visuospatial judgement: A clinical test
3. Psychopathology: Biological approaches
4. Structural brain abnormalities as indicators of vulnerability to schizophrenia
5. Diagnostic validity and laboratory studies: Rules of the games
6. Prediction of acute treatment efficacy in schizophrenic disorder
7. Biological markers and long-term prediction of schizophrenia
8. The relationship of structural brain imaging parameters to antipsychotic treatment response: A review
9. CGI. Clinical global impression
10. What are the functional consequences of neurocognitive deficit in schizophrenia?
11. Significance and meaning of neurological signs in schizophrenia
12. Negative symptoms at discharge and outcome in schizophrenia
13. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
14. Developmental processes in schizophrenia disorders: Longitudinal studies of vulnerability and stress
15. Structural brain abnormalities in the major psychoses: Quantitative review of the evidence from computerised imaging
16. Psychodiagnostické a didaktické testy
17. A review of longitudinal studies of cognitive functions in schizophrenia patients
18. Can computerised tomography be used to predict early treatment response in schizophrenia?
19. A selective review of biological markers in schizophrenia
20. Meta-analysis of studies of the ventricle brain ratio (VBR)
21. CT scan abnormalities and outcome of chronic schizophrenia